| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Badreddin Edris is Director at EWTX. Badreddin Edris's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $747K at current prices.
The EWTX filings lean toward selling, a net 115,471 shares.
Badreddin Edris has 6 Form 4 filings on record from June 2022 to June 2026, all as Director at Edgewise Therapeutics (EWTX), 2022–2026.
The 16 reported transactions were 6 option or other derivative awards, 5 option exercises and 5 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $3.4M.
The only open-market sale was 115,471 shares of EWTX at an average $29.44 on January 21, 2026, about $3.4M.